Extra! Extra! Read All About It... if you haven't already...

MiniMed's exciting new combo of the MiniMed Paradigm insulin pump and the company's REAL-TimeMinimed_combo_system_1 Continuous Glucose Monitoring (CGM) System was approved by the FDA this week. As the JDRF will tell you, this is the closest we've gotten to an artificial pancreas -- minus the fully automated "closed loop" portion -- but still a huge step forward.

Now I know why my local D-research center hasn't returned my phone calls about participating in clinical trials for this system (we'd heard rumors they were looking for adults not yet on the pump); I guess they were finished testing (!)

But I have seen the MiniMed Paradigm REAL-Time System up close and personal, because a teenager in my local support group was part of the youth study. Essentially it's the MiniMed Paradigm 522 or 722 insulin pump, worn along with a separate three-day sensor that takes continuous glucose readings and sends the data to the pump via advanced radio frequency (RF) wireless technology.

Despite the huge advantages of real-time glucose readings that your pump can display, we didn't think the system looked too comfortable. That's a bunch of technology adhered to your tummy! (see photo). But the kid wearing it was not perturbed by the double-infusion-site issue. He says it's been fantastic knowing what's happening when with his glucose. The alarm's apparently even beeped him awake at night before he got dangerously low -- one of the biggest ongoing problems for active Type 1 children, I understand.

Anyway, MiniMed's again validated its position on the cutting edge of insulin-delivery technology.

The REAL-Time continuous glucose monitoring kit will not be available until summer (sold separately as a cash pay item, not covered by most insurance plans). But the company's offering a special upgrade program for anyone who purchased a Paradigm 522 or 722 pump between April 10 and June 19 of this year. For $1,000, those folks can get started with the CGM add-on right away. I'm sure we'll be hearing reports from one of my fellow OC bloggers on this soon.

Disclaimer: Content created by the Diabetes Mine team. For more details click here.


This content is created for Diabetes Mine, a consumer health blog focused on the diabetes community. The content is not medically reviewed and doesn't adhere to Healthline's editorial guidelines. For more information about Healthline's partnership with Diabetes Mine, please click here.